Navigation Links
prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification

mRNA and a control primer set to verify reagent quality and RT-PCR procedures.

Conclusions

With Stratagenes ProSTAR RT-PCR systems, accurate cDNA amplification, high sensitivity, high product yield, and long-target capability are attainable. Use one of the two convenient kit formats, the Ultra HF RT-PCR system or the HF One-Tube RT-PCR system, to fulfill a variety of RNA amplification applications, including cDNA cloning and RNA detection/analysis.

Methods

RT-PCR reactions were carried out using the recommended protocols for the ProSTAR Ultra HF and HF Single-Tube RT-PCR systems. For the ProSTAR HF Single-Tube RT-PCR system, 50-l RT-PCR reaction mixtures contained 1X HF RT-PCR buffer, 200 M each dNTP, forward and reverse gene-specific primers (2 ng/l of each), RNA (200 ng of total RNA or 1 ng of bacteriophage MS2 RNA), 1.25 U of MMLV-RT, and 2.5 U of TaqPlus Precision DNA polymerase. Amplifications were carried out in Stratagenes RoboCycler Gradient 96 temperature cycler fitted with a Hot Top assembly, using 200-l thin-walled PCR tubes. The temperature cycling parameters for all targets incorporated the following: For cDNA synthesis, one cycle at 37C for 15 minutes (targets <2 kb) or 30 minutes (targets >2 kb); for PCR, one cycle at 95C for 1 minute; 40 cycles of 95C for 1 minute, 60C for 1 minute, and 68C for 2 minutes (targets <2 kb) or 2 minutes/kb (targets >2 kb); and one final extension cycle at 68C for 10 minutes.

For the ProSTAR Ultra HF RT-PCR system, 10-l cDNA synthesis reactions contained 1X MMLV-RT buffer, 1 mM each dNTP, 10 ng/l of oligo(dT), and RNA (200 ng of total RNA or 1 ng of bacteriophage MS2 RNA). The reaction mixtures were incubated at 65C for 5 minutes, then cooled to room temperature to allow the primers to anneal to the RNA. A total of 10 U of MMLV-RT was added, and cDNA synthesis was carried out at 37C for 15 minutes (targets <2 kb) or 3
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. New Kit Generates Exceptionally Pure Total RNA for RT-PCR
2. Brilliant Core Reagent Kits for QPCR and QRT-PCR
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. Performance Comparisons of Commercial RT-PCR Systems
5. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
6. RT-PCR Primers for the Study of Apoptosis
7. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
8. Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf cMaster RTplusPCR System
9. Optimized Dengue RT-PCR
10. QuantiTect SYBR Green RT-PCR Kit
11. C. therm. Polymerase One-Step RT-PCR System
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: prostar PCR Systems for Robust High Fidelity RNA Amplification

(Date:11/20/2008)... FORT WORTH, Texas, Nov. 20 /PRNewswire-FirstCall/...Wound Management Technologies, Inc., (WNDM),anno...icacy of their advanced,wound care collagen produ...,November/December 2008 issue of Podiatry Managem...anagement on the Leading Edge: Case Presentations ...
(Date:11/20/2008)... NEW YORK, November 20 S...eloper of biosensor and microprocessor,technologi...ed its results,for the nine-month period ended Se...eterioration in the macro-economic environment,g...421,000; declines in sales,were mainly due to the...
(Date:11/20/2008)... CLAREMONT, Calif., Nov. 20 Keck ... second annual "Next Generation Bioscience Leaders...e Industry" (NGBL) forum will be held Jan. 19-23, ...cience companies. , , The forum is a partne...pment of business leaders in bioscience, and Smith...
(Date:11/20/2008)... SAN DIEGO, Nov. 20 PacificGMP, th...ent and manufacturing, has entered into a cGMP,co...aceuticals, a,biopharmaceutical company developin...greement, PacificGMP will manufacture and perform ...ody for a Phase I/II clinical trial. A,stability...
Breaking Biology Technology:Wound Management Technologies, Inc. Announces a Published Case Study 2Wound Management Technologies, Inc. Announces a Published Case Study 3SPO Medical Reports Nine Month Period Ending September 2008 2SPO Medical Reports Nine Month Period Ending September 2008 3KGI Announces Second Annual Executive Education Conference for Women in Life Sciences 2PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing 2
...at Christopher Chitambar, a physician researcher a..., has found that a gallium compound might be an ef..., ,If the compound is found to be safe and effecti...forms of non-Hodgkin,s lymphoma that are resistant... cancer of the human lymphatic system, which is co...
...test piece of the University of Wisconsin-Milwauk...mmunity is in place. With the help of two corporat...he UWM Research Foundation, a fund-raising arm des...ation, which has been in the works for about six m...m both Wisconsin Energy Corp . and Harley-Davids...
...ertson doesn,t pretend to be a fortune teller, but...etting the standard in radiation therapy for some ...r of TomoTherapy, exudes confidence that the Hi-Ar..., will continue to be a competitive differentiator...ncremental treatments, have been delivered worldwi...
...n-based developer of predictive traffic informati...y with the help of a $1 million line of credit fro...nancial Group of Santa Clara, Calif. , , TrafficC...ort deployment of its cellular probe technology in...formation products and services in the United Stat...
Other Biology Technology:Cancer-fighting agent heads for clinical trials 2UWM launches research foundation 2TomoTherapy sees sustained market advantage 2TomoTherapy sees sustained market advantage 3TomoTherapy sees sustained market advantage 4
(Date:11/19/2008)...gie Mellon University,s Robotics Institute have re....S. Department of Agriculture (USDA) to build auto...d one is for orange growers, but both are designed...ts. , The systems use sensors on autonomous robo... to gather a multitude of data about tree health a...
(Date:11/19/2008)...of Central Florida professor show early promise fo...rofessor James Turkson,s compounds disrupt the for... on mice. The compounds, S3I-201 and S3I-M2001, b... researchers have observed no negative side effect...Turkson said. "They,ve worked very well in mice, a...
(Date:11/18/2008).../ -- Orchid Cellmark Inc.,(Nasdaq: ORCH ), a le...ervices,today reported its financial results for...s were $14.9 million for the third quarter of 2008...of 2007. The decrease in total,revenues for the ...argely due,to lower revenues in the U.K. , ...
(Date:11/18/2008)...ittsburgh have developed a simple and quick method... two substances at the center of public concern ab...a fluorescent substance that glows bright green wh...e researchers report in the current online edition.... The intensity of the glow indicates the amount o...
Breaking Biology News(10 mins):Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 2Carnegie Mellon developing automated systems to enable precision farming of apples, oranges 32 new compounds show promise for eliminating breast cancer tumors 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 2Orchid Cellmark Reports Third Quarter 2008 Financial Results 3Orchid Cellmark Reports Third Quarter 2008 Financial Results 4Orchid Cellmark Reports Third Quarter 2008 Financial Results 5Orchid Cellmark Reports Third Quarter 2008 Financial Results 6Orchid Cellmark Reports Third Quarter 2008 Financial Results 7Orchid Cellmark Reports Third Quarter 2008 Financial Results 8Pitt researchers use fluorescence to develop method for detecting mercury in fish 2Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 1Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 2Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 3Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 4Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma 22 5Promising Cystic Fibrosis Compound on Track for Development 17 1Promising Cystic Fibrosis Compound on Track for Development 17 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI 88 12 1Progen Engages Leading CRO to Assist with Phase 3 Trial of PI 88 12 2Progen Engages Leading CRO to Assist with Phase 3 Trial of PI 88 12 3Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 1Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 2Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 3Thomson Scientific Publishes The Ones to Watch A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 7 4
...niversity Hospitals Case Medical Center (UHCMC) an...ne are part of a nationwide research study to dete...ox vaccine geared toward adults ages 18 to 34 who ...e study is the first of its type in Northeast Ohio... not recommended for use on everyone because of th...
... blood test that detects proteins commonly release... tool for monitoring the effectiveness of chemothe...ed throat cancer, according to a study published i...arch . Scientists in the National Institute on Dea...d National Cancer Institute (NCI), two of the Nati...
...n the June issue of Hepatology, a journal publishe...an Association for the Study of Liver Diseases (AA...irst-ever study examining the prognostic value of ...r undergoing chemotherapy. They found that patient... a significantly increased incidence of severe hep...
...he wild tiger now occupies a mere 7 percent of its...d by tigers has declined by 41 percent over the pa...e June 2007 issue of BioScience. Growing trade in ...ns, along with habitat loss and fragmentation, is ...e assessment, by Eric Dinerstein of the World Wild...
Other Biology News:Innovative smallpox vaccine research study to be conducted at Case Medical Center 2Blood test may help signal tumor's remission, return in throat cancer patients 2Blood test may help signal tumor's remission, return in throat cancer patients 3Blood test may help signal tumor's remission, return in throat cancer patients 4Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes 2Threats to wild tigers growing 2
Request Info
384 Round Well Plate Sterile with lid; Thermo Labsystems wide range of 384-well plates is ideal for high-throughput screening and research. These allow miniaturization of assays and are suitable for
HLA-DRbeta (DA2)
BstX I from Promega
Biology Products: